Western Financial Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,646
Closed -$731K 110
2023
Q2
$731K Sell
1,646
-52
-3% -$24K 0.5% 57
2023
Q1
$781K Buy
1,698
+42
+3% +$20K 0.56% 41
2022
Q4
$850K Buy
1,656
+44
+3% +$22.3K 0.55% 38
2022
Q3
$732K Buy
1,612
+183
+13% +$87.6K 0.51% 38
2022
Q2
$690K Buy
+1,429
New +$707K 0.49% 43

Other funds holding ELV

Western Financial Corp's ELV Position: Q3 2023 in Review

Western Financial Corp sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 1,646 shares — an estimated $731K sold.

Western Financial Corp first reported a position in ELV in Q2 2022 and held it in 5 quarters. The position peaked at $850K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Western Financial Corp reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Western Financial Corp sold 1,646 Elevance Health shares in Q3 2023, an estimated $731K.
  • Western Financial Corp first reported a position in Elevance Health in Q2 2022 and held it in 5 quarters.
  • Western Financial Corp's Elevance Health position peaked at $850K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Western Financial Corp's 13F filing for Q3 2023, filed 19 Oct 2023.